HJ Research delivers in-depth insights on the global Drug Discovery market in its upcoming report titled, Global Drug Discovery Market Report 2018-2029. According to this study, the global Drug Discovery market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Drug Discovery market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Drug Discovery market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Drug Discovery industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Drug Discovery industry.
Global Drug Discovery market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Drug Discovery industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Drug Discovery market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Drug Discovery. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Drug Discovery market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Drug Discovery in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Drug Discovery market include:
Pfizer
GSK
Merck
Agilent
Eli Lilly and Company
Roche
Bayer
Abbott
AstraZeneca
Shimadzu
Market segmentation, by product types:
Small Molecule Drug
Biologics Drug
Market segmentation, by applications:
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
1 Industry Overview of Drug Discovery
1.1 Research Scope
1.2 Market Segmentation by Types of Drug Discovery
1.3 Market Segmentation by End Users of Drug Discovery
1.4 Market Dynamics Analysis of Drug Discovery
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Drug Discovery Industry
2.1 Pfizer
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Drug Discovery Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 GSK
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Drug Discovery Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Merck
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Drug Discovery Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Agilent
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Drug Discovery Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Eli Lilly and Company
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Drug Discovery Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Roche
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Drug Discovery Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Bayer
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Drug Discovery Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Abbott
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Drug Discovery Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 AstraZeneca
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Drug Discovery Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 Shimadzu
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Drug Discovery Revenue and Gross Margin (2018-2023)
2.10.4 Contact Information
3 Global Drug Discovery Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Drug Discovery by Regions (2018-2023)
3.2 Global Sales Revenue of Drug Discovery by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Drug Discovery by Types (2018-2023)
3.4 Global Sales Revenue of Drug Discovery by End Users (2018-2023)
4 Northern America Drug Discovery Market Analysis by Countries, Types and End Users
4.1 Northern America Drug Discovery Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Drug Discovery Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Drug Discovery Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Drug Discovery Sales Revenue Analysis (2018-2023)
4.5 Canada Drug Discovery Sales Revenue Analysis (2018-2023)
5 Europe Drug Discovery Market Analysis by Countries, Types and End Users
5.1 Europe Drug Discovery Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Drug Discovery Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Drug Discovery Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Drug Discovery Sales Revenue Analysis (2018-2023)
5.5 France Drug Discovery Sales Revenue Analysis (2018-2023)
5.6 UK Drug Discovery Sales Revenue Analysis (2018-2023)
5.7 Italy Drug Discovery Sales Revenue Analysis (2018-2023)
5.8 Russia Drug Discovery Sales Revenue Analysis (2018-2023)
5.9 Spain Drug Discovery Sales Revenue Analysis (2018-2023)
5.10 Netherlands Drug Discovery Sales Revenue Analysis (2018-2023)
6 Asia Pacific Drug Discovery Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Drug Discovery Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Drug Discovery Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Drug Discovery Sales Revenue Analysis by End Users (2018-2023)
6.4 China Drug Discovery Sales Revenue Analysis (2018-2023)
6.5 Japan Drug Discovery Sales Revenue Analysis (2018-2023)
6.6 Korea Drug Discovery Sales Revenue Analysis (2018-2023)
6.7 India Drug Discovery Sales Revenue Analysis (2018-2023)
6.8 Australia Drug Discovery Sales Revenue Analysis (2018-2023)
6.9 Indonesia Drug Discovery Sales Revenue Analysis (2018-2023)
6.10 Vietnam Drug Discovery Sales Revenue Analysis (2018-2023)
7 Latin America Drug Discovery Market Analysis by Countries, Types and End Users
7.1 Latin America Drug Discovery Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Drug Discovery Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Drug Discovery Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Drug Discovery Sales Revenue Analysis (2018-2023)
7.5 Mexico Drug Discovery Sales Revenue Analysis (2018-2023)
7.6 Argentina Drug Discovery Sales Revenue Analysis (2018-2023)
7.7 Colombia Drug Discovery Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Drug Discovery Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Drug Discovery Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Drug Discovery Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Drug Discovery Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Drug Discovery Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Drug Discovery Sales Revenue Analysis (2018-2023)
8.6 South Africa Drug Discovery Sales Revenue Analysis (2018-2023)
8.7 Egypt Drug Discovery Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Drug Discovery Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Drug Discovery by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Drug Discovery by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Drug Discovery by End Users (2024-2029)
10.4 Global Revenue Forecast of Drug Discovery by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Drug Discovery
11.1 Upstream Analysis of Drug Discovery
11.2 Downstream Major Consumers Analysis of Drug Discovery
11.3 Major Suppliers of Drug Discovery with Contact Information
11.4 Supply Chain Relationship Analysis of Drug Discovery
12 Drug Discovery New Project Investment Feasibility Analysis
12.1 Drug Discovery New Project SWOT Analysis
12.2 Drug Discovery New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Drug Discovery Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Drug Discovery
Table End Users of Drug Discovery
Figure Market Drivers Analysis of Drug Discovery
Figure Market Challenges Analysis of Drug Discovery
Figure Market Opportunities Analysis of Drug Discovery
Table Market Drivers Analysis of Drug Discovery
Table Pfizer Information List
Figure Drug Discovery Specifications of Pfizer
Table Drug Discovery Revenue (Million USD) and Gross Margin of Pfizer (2018-2023)
Figure Drug Discovery Revenue (Million USD) and Global Market Share of Pfizer (2018-2023)
Table GSK Information List
Figure Drug Discovery Specifications of GSK
Table Drug Discovery Revenue (Million USD) and Gross Margin of GSK (2018-2023)
Figure Drug Discovery Revenue (Million USD) and Global Market Share of GSK (2018-2023)
Table Merck Information List
Figure Drug Discovery Specifications of Merck
Table Drug Discovery Revenue (Million USD) and Gross Margin of Merck (2018-2023)
Figure Drug Discovery Revenue (Million USD) and Global Market Share of Merck (2018-2023)
Table Agilent Information List
Figure Drug Discovery Specifications of Agilent
Table Drug Discovery Revenue (Million USD) and Gross Margin of Agilent (2018-2023)
Figure Drug Discovery Revenue (Million USD) and Global Market Share of Agilent (2018-2023)
Table Eli Lilly and Company Information List
Figure Drug Discovery Specifications of Eli Lilly and Company
Table Drug Discovery Revenue (Million USD) and Gross Margin of Eli Lilly and Company (2018-2023)
Figure Drug Discovery Revenue (Million USD) and Global Market Share of Eli Lilly and Company (2018-2023)
Table Roche Information List
Figure Drug Discovery Specifications of Roche
Table Drug Discovery Revenue (Million USD) and Gross Margin of Roche (2018-2023)
Figure Drug Discovery Revenue (Million USD) and Global Market Share of Roche (2018-2023)
Table Bayer Information List
Figure Drug Discovery Specifications of Bayer
Table Drug Discovery Revenue (Million USD) and Gross Margin of Bayer (2018-2023)
Figure Drug Discovery Revenue (Million USD) and Global Market Share of Bayer (2018-2023)
Table Abbott Information List
Figure Drug Discovery Specifications of Abbott
Table Drug Discovery Revenue (Million USD) and Gross Margin of Abbott (2018-2023)
Figure Drug Discovery Revenue (Million USD) and Global Market Share of Abbott (2018-2023)
Table AstraZeneca Information List
Figure Drug Discovery Specifications of AstraZeneca
Table Drug Discovery Revenue (Million USD) and Gross Margin of AstraZeneca (2018-2023)
Figure Drug Discovery Revenue (Million USD) and Global Market Share of AstraZeneca (2018-2023)
Table Shimadzu Information List
Figure Drug Discovery Specifications of Shimadzu
Table Drug Discovery Revenue (Million USD) and Gross Margin of Shimadzu (2018-2023)
Figure Drug Discovery Revenue (Million USD) and Global Market Share of Shimadzu (2018-2023)
Table Global Revenue (Million USD) of Drug Discovery by Regions (2018-2023)
Table Global Revenue (Million USD) of Drug Discovery by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Drug Discovery by Types (2018-2023)
Table Global Revenue (Million USD) of Drug Discovery by End Users (2018-2023)
Table Northern America Drug Discovery Revenue (Million USD) by Countries (2018-2023)
Table Northern America Drug Discovery Revenue (Million USD) by Types (2018-2023)
Table Northern America Drug Discovery Revenue (Million USD) by End Users (2018-2023)
Figure United States Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Drug Discovery Revenue (Million USD) by Countries (2018-2023)
Table Europe Drug Discovery Revenue (Million USD) by Types (2018-2023)
Table Europe Drug Discovery Revenue (Million USD) by End Users (2018-2023)
Figure Germany Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Drug Discovery Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Drug Discovery Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Drug Discovery Revenue (Million USD) by End Users (2018-2023)
Figure China Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Drug Discovery Revenue (Million USD) by Countries (2018-2023)
Table Latin America Drug Discovery Revenue (Million USD) by Types (2018-2023)
Table Latin America Drug Discovery Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Drug Discovery Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Drug Discovery Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Drug Discovery Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Drug Discovery Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Drug Discovery by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Drug Discovery by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Drug Discovery by End Users (2024-2029)
Table Major Consumers with Contact Information of Drug Discovery
Table Major Suppliers of Drug Discovery with Contact Information
Figure Supply Chain Relationship Analysis of Drug Discovery
Table New Project SWOT Analysis of Drug Discovery
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Drug Discovery
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Drug Discovery Industry
Table Part of References List of Drug Discovery Industry
Table Units of Measurement List
Table Part of Author Details List of Drug Discovery Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Drug Discovery industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Drug Discovery market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Drug Discovery manufacturers, Drug Discovery raw material suppliers, Drug Discovery distributors as well as buyers. The primary sources from the supply side include Drug Discovery manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Drug Discovery raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Drug Discovery industry landscape and trends, Drug Discovery market dynamics and key issues, Drug Discovery technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Drug Discovery competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Drug Discovery market size and forecast by regions, Drug Discovery market size and forecast by application, Drug Discovery market size and forecast by types, Drug Discovery company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.